EGFR amplification and PTEN loss play critical roles in ovarian cancer progression by regulating key signaling pathways involved in cell proliferation, survival, and tumor growth by enhancing downstream signaling pathways such as PI3K-AKT. The gene discussed is AKT1; the disease is neoplasm.